200 related articles for article (PubMed ID: 36896180)
1.
Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
[TBL] [Abstract][Full Text] [Related]
3. Predominant
Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
[No Abstract] [Full Text] [Related]
4. Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.
Vedanayagam J; Chatila WK; Aksoy BA; Majumdar S; Skanderup AJ; Demir E; Schultz N; Sander C; Lai EC
Nat Commun; 2019 Aug; 10(1):3682. PubMed ID: 31417090
[TBL] [Abstract][Full Text] [Related]
5. Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.
Minna E; Devecchi A; Pistore F; Paolini B; Mauro G; Penso DA; Pagliardini S; Busico A; Pruneri G; De Cecco L; Borrello MG; Sensi M; Greco A
Front Endocrinol (Lausanne); 2023; 14():1267499. PubMed ID: 37867524
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
7. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
8. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
Wasserman JD; Sabbaghian N; Fahiminiya S; Chami R; Mete O; Acker M; Wu MK; Shlien A; de Kock L; Foulkes WD
J Clin Endocrinol Metab; 2018 May; 103(5):2009-2015. PubMed ID: 29474644
[TBL] [Abstract][Full Text] [Related]
9. DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection.
Onder S; Mete O; Yilmaz I; Bayram A; Bagbudar S; Altay AY; Issin G; Terzi NK; Iscan Y; Sormaz IC; Tunca F; Senyurek YG; Yegen G
Endocr Pathol; 2022 Dec; 33(4):437-445. PubMed ID: 36251117
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome.
van der Tuin K; de Kock L; Kamping EJ; Hannema SE; Pouwels MM; Niedziela M; van Wezel T; Hes FJ; Jongmans MC; Foulkes WD; Morreau H
J Clin Endocrinol Metab; 2019 Feb; 104(2):277-284. PubMed ID: 30260442
[TBL] [Abstract][Full Text] [Related]
11. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
[TBL] [Abstract][Full Text] [Related]
12. Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.
Wang Y; Chen SY; Ta M; Senz J; Tao LV; Thornton S; Tamvada N; Yang W; Moscovitz Y; Li E; Guo J; Shen C; Douglas JM; Ei-Naggar AM; Kommoss FKF; Underhill TM; Singh N; Gilks CB; Morin GB; Huntsman DG
Cancer Res; 2023 Nov; 83(21):3517-3528. PubMed ID: 37494476
[TBL] [Abstract][Full Text] [Related]
13. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of DICER1-mutated pituitary blastoma.
Nadaf J; de Kock L; Chong AS; Korbonits M; Thorner P; Benlimame N; Fu L; Peet A; Warner J; Ploner O; Shuangshoti S; Albrecht S; Hamel N; Priest JR; Rivera B; Ragoussis J; Foulkes WD
Acta Neuropathol; 2021 Jun; 141(6):929-944. PubMed ID: 33644822
[TBL] [Abstract][Full Text] [Related]
15. Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations.
Chernock RD; Rivera B; Borrelli N; Hill DA; Fahiminiya S; Shah T; Chong AS; Aqil B; Mehrad M; Giordano TJ; Sheridan R; Rutter MM; Dehner LP; Foulkes WD; Nikiforov YE
Mod Pathol; 2020 Jul; 33(7):1264-1274. PubMed ID: 31937902
[TBL] [Abstract][Full Text] [Related]
16. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors.
Sauer M; Barletta JA
Head Neck Pathol; 2022 Mar; 16(1):190-199. PubMed ID: 35307774
[TBL] [Abstract][Full Text] [Related]
17. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid.
Bae JS; Jung SH; Hirokawa M; Bychkov A; Miyauchi A; Lee S; Chung YJ; Jung CK
Endocr Pathol; 2021 Sep; 32(3):336-346. PubMed ID: 34313965
[TBL] [Abstract][Full Text] [Related]
19. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
[TBL] [Abstract][Full Text] [Related]
20. DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
Rutter MM; Jha P; Schultz KA; Sheil A; Harris AK; Bauer AJ; Field AL; Geller J; Hill DA
J Clin Endocrinol Metab; 2016 Jan; 101(1):1-5. PubMed ID: 26555935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
